A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients

Multidisciplinary Respiratory Medicine

Volumn 8, Issue 5, 2013, Pages

  Tselebis, Athanasios ^a   Bratis, Dionisios ^a   Pachi, Argiro ^a   Moussas, Georgios ^a   Ilias, Ioannis ^b   Harikiopoulou, Maria ^a   Theodorakopoulou, Elpida ^a   Dumitru, Silvia ^a   Kosmas, Epaminondas ^a   Vgontzas, Alexandros ^c   Siafakas, Nikolaos ^c   Tzanakis, Nikolaos ^c  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b HELENA VENIZELOU HOSPITAL   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Anxiety; COPD; Depression; Rehabilitation program

Indexed keywords

SALBUTAMOL;

ADULT; AEROBIC EXERCISE; ANGINA PECTORIS; ANXIETY; ARTICLE; BICYCLE ERGOMETRY; BREATHING EXERCISE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART INFARCTION; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MUSCLE TRAINING; PULMONARY HYPERTENSION; PULMONARY REHABILITATION;

EID: 84879893093     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-8-41     Document Type: Article

References (69)

1. Moussas G, Tselebis A, Karkanias A, Stamouli D, Ilias I, Bratis D, Vassila-Demi K: A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann Gen Psychiatry 2008, 7:7.
2. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ: Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry 2010, 25:1209-1221.
3. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, ACCP Workshop Panel on Anxiety and Depression in COPD: Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008, 134 suppl:43S-56S.
4. Wells KB, Golding J, Burnan MA: Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1998, 145:976-979.
5. Tselebis A, Gournas G, Tzitzanidou G, Panagiotou A, Ilias I: Anxiety and depression in Greek nursing and medical personnel. Psychol Rep 2006, 99:93-96. (Pubitemid 44561999)
6. Tselebis A, Bratis D, Kosmas E, Harikiopoulou M, Theodorakopoulou E, Dumitru S, Moussas G, Karkanias A, Ilias I, Siafakas N, Vgontzas A, Tzanakis N: Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease. Ann Gen Psychiatry 2011, 10:32.
7. Emery CF, Schein RL, Hauck ER, MacIntyre NR: Psychosocial and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 1998, 17:232-240. (Pubitemid 28277116)
8. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J: Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000, 355:362-368.
9. Guell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH: Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 2006, 129:899-904.
10. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C: Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007, 131(5 Suppl):4S-42S. (Pubitemid 46744215)
11. Güell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH: Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 2006, 129:899-904.
12. Withers NJ, Rudkin ST, White RJ: Anxiety and depression in severe chronic obstructive pulmonary disease: the effects ofpulmonary rehabilitation. J Cardiopulm Rehabil 1999, 19:362-365. (Pubitemid 30438894)
13. Hui KP, Hewitt AB: A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest 2003, 124:94- 97.
14. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (GOLD). . http://www.goldcopd.org.
15. Beck AT, Steer RA: Manual for the Revised Beck Depression Inventory. San Antonio, TX: Psychological Corporation; 1987.
16. Donias S, Demertzis I: Validation of the Beck depression inventory. In Proceedings of the 10th Hellenic Congress of Neurology and Psychiatry: 1983. Edited by Varfis G. Thessaloniki, Greece: University Studio Press; 1983:486-492.
17. Tselebis A, Moulou A, Ilias I: Burnout versus depression and sense of coherence: A study in Greek nursing staff. Nurs Health Sci 2001, 3:69-71. (Pubitemid 33040538)
18. Spielberger GD, Gorush RL, Lusshene RE: The State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
19. Liakos A, Giannitsi S: The validity of the Greek modification of the Spielberger anxiety scale. Encephalos 1984, 21:71-76.
20. Tselebis A, Papaleftheris E, Balis E, Theotoka I, Ilias I: Smoking related to anxiety and depression in Greek medical staff. Psychol Rep 2003, 92:529-532. (Pubitemid 39110049)
21. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S: Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006, 100:1767-1774. (Pubitemid 44283757)
22. Voekel M, Voelkel NF, MacNee W: Chronic Obstructive Lung Diseases 2. Psychosocial aspects of Chronic Obstructive Pulmonary Disease. BC Decker Inc: City; 2008.
23. Man GCW, Hsu K, Spoule BJ: Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest 1986, 90:832-836. (Pubitemid 17196171)
24. Cantor L, Jacobson R: COPD: How to manage comorbid depression and anxiety. J Fam Pract 2003, 2:11.
25. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB: Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004, 58:65-70. (Pubitemid 38351199)
26. Yohannes AM, Connolly MJ, Baldwin RC: A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2001, 16:451-454. (Pubitemid 32492377)
27. Eiser N, Harte R, Spiros K: Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2005, 2:233-241. (Pubitemid 40993298)
28. Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF: Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry 1995, 152:1531.
29. Smoller JW, Pollack MH, Systrom D, Kradin RL: Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 1998, 39:24-29. (Pubitemid 28152594)
30. Lacasse Y, Beaudoin L, Rousseau L, Maltais F: Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 2004, 61:140-147. (Pubitemid 40124039)
31. Evans M, Hammond M, Wilson K, Lye M, Copeland J: Placebo controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry 1997, 12:817-824. (Pubitemid 27390092)
32. Silvertooth EJ, Doraiswamy PM, Clary GL, Babyak MA, Wilkerson N, Hellegars C, Palmer SM: Citalopram and quality of life in lung transplant recipients. Psychosomatics 2004, 45:271-272. (Pubitemid 38621538)
33. Yohannes AM, Connolly MJ: Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression? Expert Rev Respir Med 2011, 5(6):727-729.
34. Post L, Collins C: The poorly coping COPD patient: a psychotherapeutic perspective. Int J Psychiatry Med 1981-1982, 11(2):173-182. (Pubitemid 11021961)
35. Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, Orengo CA: One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001, 31:717-723. (Pubitemid 32421972)
36. Eiser N, West C, Evans S, Jeffers A, Quirk F: Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J 1997, 10:1581-1584. (Pubitemid 27311076)
37. de Godoy DV, de Godoy RF: A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003, 84:1154-1157.
38. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray N, Stanley MA: COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients; a randomized controlled trial. Psychol Med 2008, 38:385-396. (Pubitemid 351311679)
39. Brook D: Exploring Group Therapies. Psychiatric Times 2003. http://www.psychiatrictimes.com/articles/exploring-group-therapies.
40. Dishman RK: Brain monoamines, exercise, and behavioral stress: animal models. Med Sci Sports Exerc 1997, 29(1):63-74.
41. Ransford CP: A role for amines in the antidepressant effect of exercise: a review. Med Sci Sports Exerc 1982, 14(1):1-10.
42. Dunn AL, Reigle TG, Youngstedt SD, Armstrong RB, Dishman RK: Brain norepinephrine and metabolites after treadmill training and wheel running in rats. Med Sci Sports Exerc 1996, 28(2):204-209. (Pubitemid 26067691)
43. Jacobs BL: Serotonin, motor activity and depression-related disorders. Am Sci 1994, 82:456-463.
44. Chaouloff F: Effects of acute exercise on central serotonergic systems. Med Sci Sports Exerc 1997, 29(1):58-62.
45. Raglin JS, Morgan WP: Influence of exercise and quiet rest on state anxiety and blood pressure. Med Sci Sports Exerc 1981, 19(5):456-463.
46. Carr DB, Bullen BA, Skrinar GS, Arnold MA, Rosenblatt M, Beitins IZ, Martin JB, McArthur JW: Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med 1981, 305(10):560-563. (Pubitemid 12201134)
47. Farrell PA, Gates WK, Maksud MG, Morgan WP: Increases in plasma beta endorphin/beta-lipotropinimmunoreactivity after treadmillrunning in humans. J Appl Physiol 1982, 52(5):1245-1249. (Pubitemid 12037776)
48. Gambert SR, Hagen TC, Garthwaite TL: Exercise and the endogenous opioids. N Engl J Med 1981, 305:1590-1591.
49. Pitsavos C, Chrysohoou C, Panagiotakos DB, Skoumas J, Zeimbekis A, Kokkinos P, Stefanadis C, Toutouzas PK: Association of leisure-time physical activity on inflammation markers (C-reactive protein, white cell blood count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study). Am J Cardiol 2003, 91(3):368-370. (Pubitemid 36143887)
50. Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN: Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thomb Vasc Biol 2002, 22(11):1869-1876. (Pubitemid 35315775)
51. Morrow J, Nolen-Hoeksema S: Effects of response to depression on the remediation of depressive affect. J Pers Soc Psychol 1990, 58(3):519-527.
52. Nolen-Hoeksema S, Morrow J: A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta earthquake. J Pers Soc Psychol 1991, 61(1):115-121.
53. McAuley E, Jerome GJ, Marquez DX, Elavsky S, Blissmer B: Exercise selfefficacy in older adults: social, affective, and behavioral influences. Ann Behav Med 2003, 25(1):1-7. (Pubitemid 36182453)
54. Craft LL: Exercise and clinical depression: examining two psychological mechanisms. Psychol Sport Exerc 2003, 6:151-171.
55. Lewinsohn PM, Gotlib IH: Behavioral theory and treatment of depression. In Handbook of depression. 2nd edition. Edited by Beckham EE, Leber WR. New York: Guildford Press; 1995:352-375.
56. Bartoholomew JB, Ciccolo JT: Exercise, depression, and cognition. In Exercise and its mediating effects on cognition, Volume 2. Edited by Spirduso WW, Poon LW, Chodzko-Zajko W. Champaign, IL: Human Kinetcs; 2008.
57. Tselebis A, Moussas G, Bratis D: Psychological intervention in a COPD rehabilitation programme [in Modern Greek]. Pneumonologika Themata 2006:21-23.
58. Lacasse Y, Maltais F, Goldstein RS: Pulmonary rehabilitation: an integral part of the long-term management of COPD. Swiss Med Wkly 2004, 134(41-42):601-605. (Pubitemid 39576762)
59. Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR: Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 2006, 86(1):30-36.
60. Pantou I, Harikiopoulou M, Bratis D, et al: The impact of rehabilitation-induced symptomatic, functional and psychological outcomes on health-related quality of life, European Respiratory Society, Annual Congress.; 2006.
61. Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, Hind D, Malpass A, Dickens C: The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One 2013, 8(4):e60532.
62. White RJ, Rudkin ST, Ashley J, Stevens VA, Burrows S, Pounsford JC, Cratchley G, Ambler NR: Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease. J R Coll Physicians Lond 1997, 31:541-545. (Pubitemid 127462934)
63. Pantou I, Harikiopoulou M, Mpletsa M, et al: Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation? European Respiratory Society, Annual Congress. 2007.
64. Trappenburg JC, Troosters T, Spruit MA, Vandebrouck N, Decramer M, Gosselink R: Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005, 86(9):1788-1792. (Pubitemid 41354192)
65. Edmunds M, Scudder L: Examining the Relationships Between COPD and Anxiety and Depression. Heart Lung 2009, 38:34-47.
66. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA: Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005, 127:1205-1211. (Pubitemid 46224282)
67. Hill K, Geist R, Goldstein RS: Anxiety and depression in end-stage COPD. Eur Respir J 2008, 31(3):667-677.
68. Tselebis A, Kosmas E, Bratis D, Moussas G, Karkanias A, Ilias I, Siafakas N, Vgontzas A, Tzanakis N: Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients. Ann Gen Psychiatry 2010, 9:16.
69. Papaioannou AI, Loukides S, Gourgoulianis KI, Kostikas K: Global assessment of the COPD patient: Time to look beyond FEV1? Respir Med 2009, 103:650-660.